Chronic inflammatory bowel disease and cancer

Hepato-Gastroenterology

Volumn 47, Issue 31, 2000, Pages 57-70

  Pohl, Christoph ^a   Hombach, Andreas ^b   Kruis, Wolfgang ^b  

^a Innere Abteilung   (Germany)

^b NONE

Author keywords

Colorectal cancer; M. coli; Ulcerative colitis

Indexed keywords

TUMOR MARKER;

ANEUPLOIDY; BILIARY TRACT CANCER; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; COLON FISTULA; COLON STENOSIS; COLORECTAL CANCER; CROHN DISEASE; DIFFERENTIAL DIAGNOSIS; DISEASE ACTIVITY; DISEASE DURATION; ENTERITIS; FOLIC ACID DEFICIENCY; GENE MUTATION; HISTOLOGY; HUMAN; MALIGNANT TRANSFORMATION; MORBIDITY; MORTALITY; OBSERVER VARIATION; ONSET AGE; PATIENT MONITORING; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR; SMOKING; ULCERATIVE COLITIS;

ALGORITHMS; ANEUPLOIDY; CELL TRANSFORMATION, NEOPLASTIC; CHRONIC DISEASE; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; HUMANS; INFLAMMATORY BOWEL DISEASES; MUTATION; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 0033972965     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (143)

1. 1 Crohn BB, Rosenberg H: The sigmoidoscopic picture of chronic ulcerative colitis (non-specific). Amer J Med Sci 1925; 170:220-228.
2. 2 Bargen JA: Chronic ulcerative colitis associated with malignant disease. Arch Surg 1928; 17:561-567.
3. 3 Lennard-Jones JE, Morson BC, Ritchie JK, Williams CB: Cancer surveillance in ulcerative colitis: experience over 15 years. Lancet 1983; 2:149-153.
4. 4 Ekbom A, Helmick C, Zack M, et al: Extracolonic malignancies in inflammatory bowel disease. Cancer 1991; 67:2015-2019.
5. 5 Ahsgren L, Jonsson B, Stenling R, Rutegard J: Prognosis after early onset of ulcerative colitis. A study from an unselected patient population. Hepatogastroenterology 1993; 40:467-470.
6. 6 Lennard-Jones JE, Melville DM, Morson BC, et al: Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years. Gut 1990; 7:800-806.
7. 7 Devroede GJ, Taylor FW, Sauer WG, et al: Cancer risk and life expectancy of children with ulcerative colitis. N Engl J Med 1971; 285:17-21.
8. 8 Greenstein AJ, Sachar DB, Smith H, et al: Cancer in universal and left sided colitis. Factors determining risk. Gastroenterology 1979; 77:290-294.
9. 9 Maratka ZJ, Nedbal J, Kocianova J, et al: Incidence of colorectal cancer in proctocolitis. A retrospective study of 959 cases over 40 years. Gut 1985; 26:43-49.
10. 10 Mir-Madjlessi SH, Farmer RG, Easley KA, Beck GJ: Colorectal and extracolonic malignancy in ulcerative colitis. Cancer 1986; 58:1569-1574.
11. 11 Gyde SN, Prior, Allan RN, et al: Colorectal cancer in ulcerative colitis. A cohort study of primary referrals from three centers. Gut 1988; 29:206-217.
12. 12 Katzka I, Brody RS, Morris E, Katz S: Assessment of colorectal cancer risk in patients with ulcerative colitis. Experience from a private practice. Gastroenterology 1983; 85:22-29.
13. 13 Broström O, Löfberg R, Nordenval B, et al: The risk of colorectal cancer in ulcerative colitis. An epidemiologic study. Scand J Gastroenterol 1987; 22:1193-1199.
14. 14 Gilat T, Fireman Z, Grossman A, et al: Colorectal cancer in patients with ulcerative colitis. A population study in central Israel. Gastroenterology 1988; 94:870-877.
15. 15 Ekbom A, Helmick C, Zack M, Adami O: Ulcerative colitis and colorectal cancer. A population based study. N Engl J Med 1990; 323:1228-1233.
16. 16 Greenstein AJ, Mullin GE, Strauchen JA, et al: Lymphoma in inflammatory bowel disease. Cancer 1992; 69:1119-1123.
17. 17 McNeely B, Owen DA, Pezim M: Multiple microcarcinoids arising in chronic ulcerative colitis. Am J Clin Pathol 1992; 98:112-116.
18. 18 Satsangi J, Marshall J, Roskell D, Jewell D: Ulcerative colitis complicated by renal cell carcinoma: a series of three patients. Gut 1996; 38:148-150.
19. 19 Greenstein J, Genauso R, Sachar DB: Extraintestinal cancers in inflammatory bowel disease. Cancer 1985; 56:2914-2921.
20. 20 Gillen CD, Walmsley RS, Prior P, et al: Ulcerative colitis and Crohn's disease: a comparison of the colorectal cancer risk in extensive colitis. Gut 1994; 35:1590-1592.
21. 21 Choi PM, Zelig MP: Similarity of colorectal cancer in Crohn's disease and ulcerative colitis: implications for carcinogenesis and prevention. Gut 1994; 35:950-954.
22. 22 Senay E, Sachar DB, Keohane M, et al: Small bowel carcinoma in Crohn's disease. Distinguishing features and risk factors. Cancer 1989; 63:360-363.
23. 23 Wedon DD, Shorter RG, Ilstrup DM: Crohn's disease and cancer. N Engl J Med 1973; 289:1099-1102.
24. 24 Gyde SN, Prior P, Macartney JC, et al: Malignancy in Crohn's disease. Gut 1980; 21:1024-1029.
25. 25 Bernstein D, Rogers A: Malignancy in Crohn's disease. Am J Gastroenterol 1996; 91:434-440.
26. 26 Sachar DB: Cancer in Crohn's disease. Dispelling the myths. Gut 1994; 35:651-655.
27. 27 Greenstein A, Sachar D, Smith H: Cancer in universal and left-sided ulcerative colitis. Factors determining risk. Gastroenterology 1979; 77:290-294.
28. 28 Pinczowski D, Ekbom A, Baron J, et al: Risk factors for colorectal cancer among patients with ulcerative colitis - a case control study. Gastroenterology 1994; 107:117-120.
29. 29 Broomé U, Lindberg G, Löfberg R: Primary sclerosing cholangitis in ulcerative colitis - a risk factor for the development of dysplasia and DNA-aneuploidy? Gastroenterology 1992; 102:1877-1880.
30. 30 Hanauer S: Primary sclerosing cholangitis and ulcerative colitis, potential cofactors in the dysplasia sequence. Gastroenterology 1992; 102:2161-2170.
31. 31 D'Haens GR, Lashner BA, Hanauer SB: Pericholangitis and sclerosing cholangitis are risk factors for dysplasia and cancer in ulcerative colitis. Am J Gastroenterol 1993; 88:1174-1178.
32. 32 Gurbuz KB, Giardiello FM, Bayless TM: Colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Dis Col Rect 1995; 38:37-41.
33. 33 Brentnall TA, Haggitt RC, Rabinovitch PS, et al: Risk and natural history of colonie neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 1996; 110:331-338.
34. 34 Marchesa P, Lashner BA, Lavery IC, et al: The risk of cancer and dysplasia among ulcerative colitis patients with primary sclerosing cholangitis. Am J Gastroenterol 1987; 92:1285-1288.
35. 35 Lashner BA, Turner BC, Bostwick DG, et al: Dysplasia and cancer complicating strictures in ulcerative colitis. Dig Dis Sci 1990; 35:349-352.
36. 36 Reiser JR, Waye JD, Janowitz HD, Harpaz N: Adenocarcinoma in strictures of ulcerative colitis without antecedent dysplasia by colonoscopy. Am J Gastroenterol 1994; 89:119-122.
37. 37 Lashner BA, Heidenreich PA, Su GL, et al: Effect of folate supplementation on the incidence of dysplasia and cancer in chronic ulcerative colitis. Gastroenterology 1989; 97:255-259.
38. 38 Biasco G, Zannoni U, Paganelli GM, et al: Folic acid supplementation and cell kinetics of rectal mucosa in patients with ulcerative colitis. Cancer Epidemiol Biomarkers Prev 1997; 6:469-471.
39. 39 Lashner BA, Provencher KS, Seidner DL, et al: The effect of folic acid supplementation on the risk for cancer or dysplasia in ulcerative colitis. Gastroenterology 1997; 112:29-32.
40. 40 Mortensen PB, Abildgaard K, Fallingborg J: Serum selenium concentration in patients with ulcerative colitis. Dan Med Bull 1989; 36:568-570.
41. 41 Lynch DAF, Lobo AJ, Sobala GM, et al: Failure of colonoscopic surveillance in ulcerative colitis. Gut 1993; 34:1075-1080.
42. 42 Thun M, Namboodiri N, Heath CJ: Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 1991; 325:1593-1596.
43. 43 Odes HS, Fraser D: Ulcerative colitis in Israel. Epidemiology, morbidity and genetics. Public Health Rev 1989/90; 17:297-319.
44. 44 Langholtz E, Munkholm P, Davidsen M, et al: Colorectal cancer risk and mortality in patients with ulcerative colitis. Gastroenterology 1992; 103:1444-1451.
45. 45 Moody GA, Jayanthi V, Probert CS, et al: Long-term therapy with sulphasalazine protects against colorectal cancer in ulcerative colitis: a retrospective study of colorectal cancer risk and compliance with treatment in Leicestershire. Eur J Gastroenterol Hepatol 1996; 12:1179-1183.
46. 46 Ekbom A: Cancer in inflammatory bowel disease. In: Caprilli E (Ed.). Inflammatory bowel disease. Stuttgart: Schattauer, 1997; pp. 91-97.
47. 47 Greenstein AJ, Slater G, Heimann TM, et al: A comparison of multiple synchronous colorectal cancer in ulcerative colitis, familial polyposis coli, and de novo cancer. Ann Surg 1986; 203:123-128.
48. 48 Levin B: Ulcerative colitis and colon cancer: biology and surveillance. J Cell Biochem 1992; 16(Suppl):47-50.
49. 49 Connell WR, Talbot IC, Harpaz N, et al: Clinicopathological characteristics of colorectal carcinoma complicating ulcerative colitis. Gut 1994; 35:1419-1423.
50. 50 Shelton AA, Lehman RE, Schrock TR, Welton ML: Retrospective review of colorectal cancer in ulcerative colitis at a tertiary center. Arch Surg 1996; 131:806-811.
51. 51 Heimann TM, Oh SC, Martinelli G, et al: Colorectal carcinoma associated with ulcerative colitis: a study of prognostic indicators. Am J Surg 1992; 164:13-17.
52. 52 Chapuis PH, Dent OF, Fisher R, et al: A multivariate analysis of clinical and pathological variables in prognosis after resection of large bowel cancer. Brit J Surg 1985; 72:698-702.
53. 53 Desaint B Legrende C Florent C: Dysplasia and cancer in ulcerative colitis. Hepatogastroenterology 1989; 36:219-226.
54. 54 Bachwich DR, Lichtenstein GR, Traber PG: Cancer in inflammatory bowel disease. Med Clin North Am 1994; 78:1399-1412.
55. 55 Michelassi F, Montag AG, Block GE: Adenosquamous-cell carcinoma in ulcerative colitis. Report of a case. Dis Colon Rectum 1988; 31:323-326.
56. 56 Yaziji H, Broghamer WL Jr: Primary small cell undifferentiated carcinoma of the rectum associated with ulcerative colitis. South Med J 1996; 89:921-924.
57. 57 Martinelli G, Szporn A, Luppescu N, et al: Colorectal carcinoma associated with ulcerative colitis: a study of prognostic indicators. Am J Surg 1992; 164:13-17.
58. 58 Gronowitz M, Kilander AF, Holmgren J, et al: Serum levels of the carcinoma-associated antigen CA 50 in ulcerative colitis. Scand J Gastroenterol 1987; 22:239-242.
59. 59 Thor A, Itzkowitz SH, Schlom J, et al: Tumor-associated glycoprotein (TAG-72) expression in ulcerative colitis. Int J Cancer 1989; 43:810-815.
60. 60 Allen DC, Biggart JD, Orchin JC, Foster H: An immunoperoxidase study of epithelial marker antigens in ulcerative colitis with dysplasia and carcinoma. J Clin Pathol 1985; 38:18-29.
61. 61 Nathrath WB, Schuppel RH, Wiebecke B, Bjorklund B: Distribution of tissue polypeptide antigen (TPA) in normal mucosa, in colitis ulcerosa, in adenomas and in carcinomas of the human colorectum. An immunohistochemical study. APMIS 1988; 96:509-518.
62. 62 Allen DC, Connolly NS, Biggart JD: Mucin profiles in ulcerative colitis with dysplasia and carcinoma. Histopathology 1988; 13:413-424.
63. 63 Filipe MI, Sandey A, Ma J: Intestinal mucin antigens in ulcerative colitis and their relationship with malignancy. Hum Pathol 1988; 19:671-681.
64. 64 Noffsinger AE, Miller MA, Cusi MV, Fenoglio-Preiser CM: The pattern of cell proliferation in neoplastic and non-neoplastic lesions of ulcerative colitis. Cancer 1996; 78:2307-12.
65. 65 Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 1990; 60:759-767.
66. 66 Morson BC, Pang LSC: Rectal biopsy as an aid to cancer control in ulcerative colitis. Gut 1967; 8:423-434.
67. 67 Butt JH, Konishi J, Morson BM, Lennard-Jones JE: Lesions in dysplasia and carcinoma complicating ulcerative colitis. Dig Dis Sci 1983; 28:18-28.
68. 68 Riddell RH, Goldman H, Ransohoff DF, et al: Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical application. Hum Pathol 1983; 14:931-968.
69. 69 Blackstone MO, Riddell RH, Rogers BHG, Levin B: Dysplasia associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy. Gastroenterology 1981; 80:366-374.
70. 70 Levin B: Ulcerative colitis and colon cancer: biology and surveillance. J Cell Biochem 1992; 16(Suppl):47-50.
71. 71 Allen DC, Hamilton PW, Watt PC, Biggart JD: Morphometrical analysis in ulcerative colitis with dysplasia and carcinoma. Histopathology 1987; 11:913-926.
72. 72 Leidenius M, Kellokumpu I, Husa A, et al: Dysplasia and carcinoma in longstanding ulcerative colitis: an endoscopic and histological surveillance program. Gut 1991; 32:1521-1525.
73. 73 Schneider A, Stolte M: Clinical and pathomorphological findings in patients with colorectal carcinoma complicating ulcerative colitis. Z Gastroenterol 1993; 31:192-197.
74. 74 Allen DC, Biggart JD, Pyper PC: Large bowel mucosal dysplasia and carcinoma in ulcerative colitis. J Clin Pathol 1985; 38:30-43.
75. 75 Oikawa T: Morphological and immunohistochemical quantitative analysis of dysplasia in ulcerative colitis. II. Immunohistochemical quantitative analysis. Nippon Shokakibyo Gakkai Zasshi 1992; 89:601-609.
76. 76 Konishi F, Wakasa H, Kino I, et al: Histological classification of the neoplastic changes arising in ulcerative colitis: a new proposal in Japan. J Gastroenterol 1995; 30(Suppl 8):20-24.
77. 77 Melville DM, Jass JR, Morson BC, et al: Observer study of the grading of dysplasia in ulcerative colitis: comparison with clinical outcome. Hum Pathol 1989; 20:1008-1014.
78. 78 Lofberg R, Brostrom O, Karlen P, et al: Colonoscopic surveillance in long-standing total ulcerative colitis - a 15-year follow-up study. Gastroenterology 1990; 99:1021-1031.
79. 79 Connell WR, Lennard-Jones JE, Williams CB: Factors affecting the outcome of endoscopie surveillance for cancer in ulcerative colitis. Gastroenterology 1994; 107:934-944.
80. 80 Bernstein CN, Shanahan F, Weinstein WM: Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? Lancet 1994; 343:71-74.
81. 81 Taylor BA, JH Pemberton, HA Carpenter: Dysplasia in chronic ulcerative colitis: implications for colonoscopic surveillance. Dis Colon Rectum 1992; 35:950-956.
82. 82 Rubin CE, Haggitt RC, Burmer GC, et al: DNA aneuploidy in colonie biopsies predicts future development of dysplasia in ulcerative colitis. Gastroenterology 1992; 103:1611-1620.
83. 83 Woolrich AJ, Da Silva MD, Korelitz BI: Surveillance in the routine management of ulcerative colitis: the predictive value of low-grade dysplasia. Gastroenterology 1992; 103:431-438.
84. 84 Okayasu I, Ohkusa T, Kajiura K, et al: Promotion of colorectal neoplasia in experimental murine ulcerative colitis. Gut 1996; 39:87-92.
85. 85 Babbs CF: Oxygen radicals in ulcerative colitis. Free Radic Biol Med 1992; 13:169-181.
86. 86 Hill MJ, Melville DM, Lennard-Jones JE, et al: Faecal bile acids, dysplasia, and carcinoma in ulcerative colitis. Lancet 1987; 2:185-186.
87. 87 Roediger WE, Lawson MJ, Radcliffe BC: Nitrite from inflammatory cells - a cancer risk factor in inflammatory cells. Dis Colon Rectum 1990; 33:1034-1036.
88. 88 Rosenberg IH, Mason J: Folate, dysplasia and cancer. Gastroenterology 1989; 97:502-505.
89. 89 Heinen CD, Noffsinger AE, Belli J, et al: Regenerative lesions in ulcerative colitis are characterized by microsatellite mutation. Genes Chromosomes Cancer 1997; 19:170-175.
90. 90 Lofberg R, Tribukait B, Ost A, et al: Flow cytometric DNA analysis in longstanding ulcerative colitis: a method of prediction of dysplasia and carcinoma development? Gut 1987; 28:1100-1106.
91. 91 Rutegard J, Ahsgren L, Stenling R, Roos G: DNA content and mucosal dysplasia in ulcerative colitis. Flow cytometric analysis in patients with dysplastic or indefinite morphologic changes in the colorectal mucosa. Dis Colon Rectum 1989; 32:1055-1059.
92. 92 Befrits R, Hammarberg C, Rubio C, et al: DNA aneuploidy and histologic dysplasia in long-standing ulcerative colitis. A 10-year follow-up study. Dis Colon Rectum 1994; 37:313-320.
93. 93 Levine DS, Rabinovitch PS, Haggitt RC, et al: Distribution of aneuploid cell populations in ulcerative colitis with dysplasia or cancer. Gastroenterology 1991; 101:1198-210.
94. 94 Meling GI, Clausen OP, Bergan A, et al: Flow cytometric DNA ploidy pattern in dysplastic mucosa, and in primary and metastatic carcinomas in patients with longstanding ulcerative colitis. Br J Cancer 1991; 64:339-344.
95. 95 Suzuki K, Muto T, Masaki T, Mzimbalist Y, Plumer EH, Rorioka A: Microspectrophotometric DNA analysis in ulcerative colitis with special reference to its application in diagnosis of carcinoma and dysplasia. Gut 1990; 31:1266-1270.
96. 96 Burmer GC, Rabinovitch PS, Haggitt RC: Neoplastic progression in ulcerative colitis: histology, DNA content, and loss of a p53 allele. Gastroenterology 1992; 103:1602-1610.
97. 97 Lofberg R, Brostrom O, Karlen P, et al: DNA aneuploidy in ulcerative colitis: reproducibility, topographic distribution, and relation to dysplasia. Gastroenterology 1992; 102:1149-1154.
98. 98 Cuvelier CA, Morson BC, Roels HJ: The DNA content in cancer and dysplasia in chronic ulcerative colitis. Histopathology 1987; 11:927-939.
99. 99 Fozard JB, Quirke P, Dixon MF, et al: DNA aneuploidy in ulcerative colitis. Gut 1986; 27:1414-1418.
100. 100 Zimbalist EH, Plumer AR: Genetic and environmental factors in colorectal cancer. Dig Dis 1995; 13:365-378.
101. 101 Brentnall TA, Rubin CE, Crispin DA, et al: A germline substitution in the human MSH2 gene is associated with high-grade dysplasia and cancer in ulcerative colitis. Gastroenterology 1995; 109:151-155.
102. 102 Greenwald BD, Harpaz N, Yin J, et al: Loss of heterozygosity affecting the p53, Rb, and mcc/apc tumor suppressor gene loci in dysplastic and cancerous ulcerative colitis. Cancer Res 1992; 52:741-745.
103. 103 Kern SE, Redston M, Seymour AB, et al: Molecular genetic profiles of colitis-associated neoplasms. Gastroenterology 1994; 107:420-428.
104. 104 Tarmin L, Yin J, Harpaz N, et al: Adenomatous polyposis coli gene mutations in ulcerative colitis-associated dysplasias and cancers versus sporadic colon neoplasms. Cancer Res 1995; 55:2035-2038.
105. 105 Burmer GC, Crispin DA, Kolli VR, et al: Frequent loss of a p53 allele in carcinomas and their precursors in ulcerative colitis. Cancer Commun 1991; 3:167-172
106. 106 Taylor HW, Boyle M, Smith SC, et al: Expression of p53 in colorectal cancer and dysplasia complicating ulcerative colitis. Br J Surg 1993; 80:442-444.
107. 107 Chaubert P, Benhattar J, Saraga E, Costa J: K-ras mutations and p53 alterations in neoplastic and non-neoplastic lesions associated with longstanding ulcerative colitis. Am J Pathol 1994; 144:767-775.
108. 108 Brentnall TA, Crispin DA, Rabinovitch PS, et al: Mutations in the p53 gene: an early marker of neoplastic progression in ulcerative colitis. Gastroenterology 1994; 107:369-378.
109. 109 Harpaz N, Peck AL, Yin J, et al: p53 protein expression in ulcerative colitis-associated colorectal dysplasia and carcinoma. Hum Pathol 1994; 25:1069-1074.
110. 110 Benhattar J, Saraga E: Molecular genetics of dysplasia in ulcerative colitis. Eur J Cancer 1995; 31A:1171-1173.
111. 111 Ilyas M, Talbot IC: p53 expression in ulcerative colitis: a longitudinal study. Gut 1995; 37:802-804.
112. 112 Lei J, Zou TT, Shi YQ, et al: Infrequent DPC4 gene mutation in esophageal cancer, gastric cancer and ulcerative colitis-associated neoplasms. Oncogene 1996; 13:2459-2462.
113. 113 Hoque AT, Hahn SA, Schutte M, Kern SE: DPC4 gene mutation in colitis associated neoplasia. Gut 1997; 40:120-122.
114. 114 Willenbucher RF, Zelman SJ, Ferrell LD, et al: Chromosomal alterations in ulcerative colitis-related neoplastic progression. Gastroenterology 1997; 113:791-801.
115. 115 Burmer GC, Levine DS, Kulander BG, et al: c-Ki-ras mutations in chronic ulcerative colitis and sporadic colon carcinoma. Gastroenterology 1990; 99:416-420.
116. 116 Bell SM, Kelly SA, Hoyle IA, et al: c-Ki-ras gene mutations in dysplasia and carcinomas complicating ulcerative colitis. Br J Cancer 1991; 64:174-178.
117. 117 Chen J, Compton C, Cheng E, et al: c-Ki-ras mutations in dysplastic fields and cancers in ulcerative colitis. Gastroenterology 1992; 102:1983-1987.
118. 118 Burmer GC, Rabinovitch PS, Loeb LA: Frequency and spectrum of c-Ki-ras mutations in human sporadic colon carcinoma, carcinomas arising in ulcerative colitis, and pancreatic adenocarcinoma. Environ Health Perspect 1991; 93:27-31.
119. 119 Tsuda T, Mochizuki M, Wakasa H: Detection of c-ras gene mutation and expression of p21 protein in dysplasias and carcinomas complicating ulcerative colitis. J Gastroenterol 1995; 30(Suppl 8):30-32.
120. 120 Cartwright CA, Coad CA, Egbert BM: Elevated c-Src tyrosine kinase activity in premalignant epithelia of ulcerative colitis. J Clin Invest 1994; 93:509-515.
121. 121 Malecka-Panas E, Kordek R, Biernat W, et al: Differential activation of total and EGF receptor (EGF-R) tyrosine kinase (tyr-k) in the rectal mucosa in patients with adenomatous polyps, ulcerative colitis and colon cancer. Hepatogastroenterology 1997; 44:435-440.
122. 122 Ilyas M, Tomlinson IP, Hanby AM, et al: Bcl-2 expression in colorectal tumors: evidence of different pathways in sporadic and ulcerative-colitis-associated carcinomas. Am J Pathol 1996; 149:1719-1726.
123. 123 Gyde SN: Screening for colorectal cancer in ulcerative colitis. Dubious benefits and high costs. Gut 1990; 31:1089-1092.
124. 124 Lashner BA, Kane SV, Hanauer SB: Colon cancer surveillance in chronic ulcerative colitis. Historical cohort study. Amer J Gastroenterol 1990; 85:1083-1087.
125. 125 Rosenstock E, Farmer RG, Petras R, et al: Surveillance for colonie carcinoma in ulcerative colitis. Gastroenterology 1985; 89:1342-1346.
126. 126 Manning AP, Bulgim OR, Dixon MF, Axon AT: Screening by colonoscopy for colonie epithelial dysplasia in inflammatory bowel disease. Gut 1987; 28:1489-1494.
127. 127 Rutegard J, Ahsgren L, Stenling R, Janunger KG: Ulcerative colitis. Cancer surveillance in an unselected population. Scand. J Gastroenterol 1988; 23:139-145.
128. 128 Korelitz BI: Considerations of surveillance, dysplasia, and carcinoma of the colon in the management of ulcerative colitis and Crohn's disease. Med Clin North Am 1990; 74:189-199.
129. 129 Jonsson B, Ahsgren L, Andersson LO, et al: Colorectal cancer surveillance in patients with ulcerative colitis. Br J Surg 1994; 81:689-691.
130. 130 Suzuki K, Muto T, Shinozak Mi, et al: Results of cancer surveillance in ulcerative colitis. J Gastroenterol 1995; 30(Suppl 8):40-42.
131. 131 Vilien M, Jorgensen MJ, Ouyang Q, et al: Colonic epithelial dysplasia or carcinoma in a regional group of patients with ulcerative colitis of more than 15 years duration. J Intern Med 1991; 230:259-263.
132. 132 Lynch DA, Lobo AJ, Sobala GM, et al: Failure of colonoscopic surveillance in ulcerative colitis. Gut 1993; 34:1075-1080.
133. 133 Choi PM, Nugent FW, Schoetz DJ Jr, et al: Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis. Gastroenterology 1993; 105:418-424.
134. 134 Turunen MJ, Jarvinen H: Cancer in ulcerative colitis: what failed in follow-up? Acta Chir Scand 1985; 151:669-673.
135. 135 Riddell RH: Grading of dysplasia. Eur J Cancer 1995; 31A:1169-1170.
136. 136 Bresalier RS, Kim YS: Malignant neoplasms of the large intestine. In: Feldmann M, Scharschmidt BF, Sleisenger MH (Eds.). Gastrointestinal and liver disease. 6th Edition. Philadelphia USA: WB Saunders, 1998; pp. 1096-1972.
137. 137 Ahnen DJ: Dysplasia and chronic ulcerative colitis. In: Rustgi A (Ed.). Gastrointestinal cancers: Biology, Diagnosis and Therapy. Philadelphia, USA: J.B. Lippincott, 1995; p. 399.
138. 138 Stelzner M, Fonkalsrud EW: The endorectal ileal pullthrough procedure in patients with ulcerative colitis and familial polyposis with carcinoma. Surg Gynecol Obstet 1993; 169:187-194.
139. 139 Kollmorgen CF, Nivatvongs S, Dean PA, Dozois RR: Long-term causes of death following ileal pouch-anal anastomosis. Dis Colon Rectum 1996; 39:525-528.
140. 140 Johnson WR, Hughes ES, McDermott FT, et al: The outcome of patients with ulcerative colitis managed by subtotal colectomy. Surg Gynecol Obstet 1986; 162:421-425.
141. 141 Thomas DM, Filipe MI, Smedley FH: Dysplasia and carcinoma in the rectal stump of total colitics who have undergone colectomy and ileo-rectal anastomosis. Histopathology 1989; 14:289-298.
142. 142 Lofberg R, Leijonmarck CE, Brostrom O, et al: Mucosal dysplasia and DNA content in ulcerative colitis patients with ileorectal anastomosis. Follow-up study in a defined patient group. Dis Colon Rectum 1991; 34:566-571.
143. 143 Giebel GD, Sabiers H: Ileal pouch-anal anastomosis for ulcerative colitis and polyposis coli: is the risk of carcinoma formation conclusively averted? Eur J Surg Oncol 1996; 22:372-376.